Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dx Firms Should Measure Patient Outcomes During Pivotal Trials – Consultant

This article was originally published in The Gray Sheet

Executive Summary

Diagnostic firms aiming to conduct a single trial to satisfy both FDA and CMS requirements could examine patient outcomes retrospectively, according to Eleanor Perfetto, PhD, The Weinberg Group

You may also be interested in...



Medicare Will Cover PET To Distinguish Alzheimer’s From Other Dementia

CMS' decision to provide national coverage of FDG-PET imaging for some suspected dementia patients corresponds with the Neuroimaging Work Group of the Alzheimer's Association's consensus position

Medicare Will Cover PET To Distinguish Alzheimer’s From Other Dementia

CMS' decision to provide national coverage of FDG-PET imaging for some suspected dementia patients corresponds with the Neuroimaging Work Group of the Alzheimer's Association's consensus position

PET Community Coalesces For Alzheimer’s Disease Diagnosis Coverage

Reimbursement of positron emission tomography for diagnosing Alzheimer's disease will be contingent on the PET community's mobilization and grassroots efforts, according to Rep. Nancy Johnson (R-Conn.)

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel